Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Abilify

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Abilify was produced by Otsuka and Bristol-Myers Squibb.

Patent cliff losses set to cost pharma $65bn by 2019

Patent cliff losses set to cost pharma $65bn by 2019 Dion added that, although Otsuka's anti-psychotic drug Abilify (aripiprazole) - co-owned with Bristol-Myers Squibb - was the sales leader in CNS, bringing in $9.5bn in 2013, the future

Lundbeck still feeling effects from Cipralex patent loss

Lundbeck still feeling effects from Cipralex patent loss There were also gains for Lundbeck's new schizophrenia drug Abilify Maintena (aripiprazole) - although the company did not reveal figures - and the start of contributions from alcohol dependency treatment Selincro (nalmefene)

Amgen biosimilar matches AbbVie's Humira in psoriasis trial

Amgen biosimilar matches AbbVie's Humira in psoriasis trial Enbrel. Amgen/Pfizer. 8, 897. Seretide/Advair. GSK. 8, 356. Abilify. BMS/Otsuka. 8, 031.

Lundbeck launches Brintellix in first EU market

Lundbeck launches Brintellix in first EU market Since then, the company has launched not only Brintellix but also a long-acting version of schizophrenia drug Abilify (aripiprazole) and alcohol addiction treatment Selincro (nalmefene) that have allowed it to

This month in 1989: the creation of Bristol-Myers Squibb

This month in 1989: the creation of Bristol-Myers Squibb It's a strategy that paid off and BMS has continued to be one of the leading global pharma companies, launching products such as antidepressant Abilify (aripiprazole) and diabetes standard Glucophage

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics